Recall: Farser Kai Yang Pill Unapproved Drug Claims
Murray International Trading Co. recalls Farser Kai Yang Pill due to unapproved drug labeling. Check your bottle for Chinese characters and lot details.
Use caution until it’s fixed
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Contact the company
What happened, in plain English
Murray International Trading Co., Inc. is recalling the Farser Kai Yang Pill because it is marketed as a dietary supplement but contains labeling with disease claims, classifying it as an unapproved drug. The product is packaged in a bottle within a box and was made in The Peoples Republic of China. All lots are included in this recall. Read more at govinfonow.com/recall/42875-recall-farser-kai-yang-pill-unapproved-drug-claims.
Source Summary by GovInfoNow · govinfonow.com/recall/42875-recall-farser-kai-yang-pill-unapproved-drug-claims · Updated October 11, 2026 · FDA enforcement record: FDA #D-1355-2016
Cite this page
“Recall: Farser Kai Yang Pill Unapproved Drug Claims.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/42875-recall-farser-kai-yang-pill-unapproved-drug-claims. Based on FDA recall #D-1355-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1355-2016%22&limit=1).
Why it’s dangerous
The product bears labeling with drug or disease claims while being marketed as a dietary supplement. This makes it an unapproved drug under federal law, meaning its safety and efficacy have not been verified by the FDA through the standard approval process.
Who’s affected
Consumers who purchased the Farser Kai Yang Pill, distributed nationwide including Puerto Rico, may have this product. Individuals using it for health conditions implied by the labeling are at risk of relying on an unapproved treatment.
How to tell if you have this one
Look for a bottle within a box labeled 'FARSER KAI YEUNG PILL' made in The Peoples Republic of China. The packaging contains Chinese characters on the remaining labeling. All lots are affected.
- Brand
Farser Kai Yang Pill- Category
Drug
All 14 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide and Puerto Rico
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1345-2016 | PATCH-REMOUING PILL (For Facial Pigmentation), packaged in a bottle within a box, Kwang Chow Pharm. Ind. Corp., remaining labeling contains Chinese characters.; All lots | 84 bottles |
| D-1346-2016 | ChingChunBao ANTI-AGING TABLETS, packaged in 80-count bottles within a box, UPC 0 49987 01144 9, remaining labeling contains Chinese characters.; All lots | 204 bottles |
| D-1347-2016 | FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.; All lots | unknown |
| D-1348-2016 | SCIATICA PILLS, packaged in 120-count bottles within a box, Made in the Peoples Republic of China, remaining labeling contains Chinese characters.; All lots | 144 bottles |
| D-1349-2016 | CROCODILE BILE PILL FOR ASTHMA, packaged in 100-count bottles within a box, remaining labeling contains Chinese characters.; All lots | 48 bottles |
| D-1350-2016 | Tien Ma Tou Tong Wan (Condensed pills), packaged in 100-count bottles within a box, Kwangchow First Chinese Medicine Factory, Kwangchow, China; remaining labeling contains Chinese characters.; All lots | 96 bottles |
| D-1351-2016 | LARYNGITIS PILLS Herbal Supplement, packaged in 10-count packets containing 3 tubes per packet within a box, Produced by: Good Harvests (Asia) Trading Co., Ltd.; Imported by: Murray Int'l Trading Co., Inc., New York, NY 10013; UPC 7 67533 86925 1, remaining labeling contains Chinese characters.; All lots | 178 boxes |
| D-1352-2016 | PEKING NIU-HUANG CHIEH-TU-PIEN Tablets (Sugar Coated), packaged in 50-count bottles within a box, BEIJING TUNG JEN TANG. BEIJING CHINA; remaining labeling contains Chinese characters.; All lots | Unknown |
| D-1353-2016 | GASTRODIA CAPSULES, packaged in 30-count bottles within a box, LANZHOU MANUFACTORY OF CHINA. GANSU CHINA; remaining labeling contains Chinese characters.; All lots | Unknown |
| D-1354-2016 | WUPOOSER KAI YEUNG PILL, packaged in a bottle within a box, Made in The Peoples Republic of China, remaining labeling contains Chinese characters.; All lots | Unknown |
| D-1355-2016 | FARSER KAI YEUNG PILL, packaged in a bottle within a box, Made in The Peoples Republic of China, remaining labeling contains Chinese characters.; All lots | Unknown |
| D-1356-2016 | PING ON OINTMENT RELIEF FOR MUSCULAR PAIN, packaged in a packet of 12-count 8gm containers within a box, PING ON OINTMENT CO LTD, PING ON OINTMENT INTERNATIONAL LTD, 149 Queen's Road West, Hong Kong, UPC 8 33679 00001 5, remaining labeling contains Chinese characters.; All lots | 216 packets |
| D-1357-2016 | Te Xiao BaiNeiTing Herbal Supplement (Naphazoline HCl Solution 0.1%) liquid, Net Wt. 15ml, packaged in a bottle within a box, Produced by: Good Harvests (Asia) Trading Co., Ltd, Imported by Murray Int'l Trading Co., Inc. New York, NY 10013, UPC 7 67533 86115 6, remaining labeling contains Chinese characters.; All lots | 17 boxes |
| D-1358-2016 | FUQINGSONG RELIEF CREAM (Flucinonide Ointment), packaged in 50-count individually labeled pieces Net Wt. 0.32oz (10g) within a box, MANUFACTURED BY: TIANJIN MAEDICAL & PHARMACEUTICAL CO., LTD. ADDREST: 96 BAWAEI ROAD, HEDONG COUNTY, TIANJIN CITY, remaining labeling contains Chinese characters.; All lots | 97 boxes |
What to do — step by step
Stop using the product
Discontinue use of the Farser Kai Yang Pill immediately as it is an unapproved drug.
Dispose of or return the item
The record does not specify a specific remedy, disposal method, or contact information for returns.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1355-2016 (April 20, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1355-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.